Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

77 open positions at argenx

View Full Profile

Filters:Immunology ×

Head of Rewards & Recognition, Developed Markets

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Team Lead Finance Operations (AP & FBS)

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Toxicologist late stage clinical development and established Assets

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Digital Technology Business Lead - Research

argenx

Posted 3mo ago

Gent, Belgium

Full-time

DT Strategic Partnerships Lead

argenx

Posted 3mo ago

Remote

Full-time

Digital Technology Product Owner, US Market Access

argenx

Posted 3mo ago

Boston, MA, USA

$156K - $215K

Full-time

Digital Technology Product Owner, US HCP Experience

argenx

Posted 3mo ago

Boston, MA, USA

$184K - $253K

Full-time

Head of U.S. Regulatory Advertising & Promotion and Strategic Commercialization

argenx

Posted 3mo ago

Remote

$268K - $369K

Full-time

Principal Scientist Bioanalytics

argenx

Posted 4mo ago

Gent, Belgium

Full-time

Biomarker Biostatistics Lead

argenx

Posted 5mo ago

Gent, Belgium

Full-time

Director of Medical Writing

argenx

Posted 6mo ago

Remote

$212K - $292K

Full-time

Reporting & Insights Lead

argenx

Posted 6mo ago

Gent, Belgium

Full-time

Clinical Operations Development Lead

argenx

Posted 6mo ago

Remote

Medical Safety Lead

argenx

Posted 6mo ago

Remote

$292K - $402K

Full-time

Senior Medical Writer

argenx

Posted 6mo ago

Remote

$128K - $176K

Full-time

Medical Science Liaison, (São Paulo, Brazil)

argenx

Posted 8mo ago

Brazil - Field

Full-time

Associate Director Field Based Market Access, Germany

argenx

Posted 1y ago

Germany - Field

Full-time

Previous
1
2
3

Company Overview

Active Jobs

84

Pipeline Programs

88

Drug Products

2

Clinical Trials

98

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

FinanceImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Clinical DevelopmentImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteBusiness DevelopmentImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Data ScienceImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical OperationsImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Medical AffairsImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialImmunologyEntry

H-1B · 1 FY23